# Amgen Inc. (AMGN) — Q3-2021 Earnings Results

**Report date:** 2021-11-02 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2021

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Up 2.13%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $4.67 | N/A | +10.66% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in the company's current trajectory. They noted the importance of maintaining focus on core products and future growth opportunities.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They emphasized ongoing commitment to innovation and pipeline development.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

Amgen's strong earnings per share performance indicates better-than-expected profitability, which likely contributed to the positive stock reaction. Investors may view the EPS beat as a sign of resilience in the company's operations. However, the lack of revenue data and guidance leaves some uncertainty about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2021_